CRITICAL REVIEW OF DRUG TREATMENT FOR ALZHEIMER DISEASE

Critical Review

The final assignment for this class will be a 10-page critical review of the drug treatment for a psychiatric disorder (broadly defined to include psychological and neurological disorders as well). The review will use peer-reviewed sources to evaluate the current drug treatment modalities for the selected disorder and determine the adequacy of those treatments. The paper will be evaluated on the inclusion of the following information:

Introduction 
Evaluate the disorder in terms of symptomatic and behavioral presentation. Include the time, course, and progression of the disorder. Evaluate and explain special features of the disease epidemiology.

Theory
Evaluate the predominant theory or theories regarding the biological basis of the disorder. Explain the disorder in terms of pertinent neurotransmitter and receptor theories and describe the pertinent evidence of their involvement. Analyze the neurotransmitter systems in terms of the involved receptors and the use receptor agonists and antagonists in the treatment of the disorder receptor. Include information on the anatomic changes to the central nervous system as appropriate to the topic.

Treatment 
Evaluate drug therapies for treating the disorder based on the current understanding of the biological basis of the disorder and the corresponding behavioral effects of the disorder. Explain pharmacokinetics and pharmacodynamics in relation to the disorder and corresponding drug treatment. Describe any side effects and adverse effects of the drug treatment and their biological basis, including issues related to contraindications, interactions, drug metabolism, and elimination. In addition, explain risks, benefits, and ethical implications for high-risk and exceptional treatment conditions.

Conclusion 
Summarize theories of psychiatric disease as they relate to principles of drug action within the chosen topic. Evaluate advantages and disadvantages of the current theory of the disorder and its treatment and evaluate any controversies regarding ethical and/or risk-benefits perspectives associated with the current treatment. Describe possible areas for future research.

Attention Students: The Masters of Arts in Psychology program is utilizing the Pathbrite portfolio tool as a repository for student scholarly work in the form of signature assignments completed within the program. After receiving feedback for this Critical Review, please implement any changes recommended by the instructor, go to Pathbrite (Links to an external site.)Links to an external site.and upload the revised Critical Review to the portfolio. (Use the Pathbrite Quick-Start Guide (Links to an external site.)Links to an external site. to create an account if you do not already have one.) The upload of signature assignments will take place after completing each course. Be certain to upload revised signature assignments throughout the program as the portfolio and its contents will be used in other courses and may be used by individual students as a professional resource tool. See the Pathbrite(Links to an external site.)Links to an external site. website for information and further instructions on using this portfolio tool.

Writing the Critical Review
The paper:

• Must be 10 to 12 double-spaced pages in length (not including title and reference pages) and formatted according to APA style as outlined in the Ashford Writing Center. (Links to an external site.)Links to an external site.
• Must include a separate title page with the following:
  • Title of paper
  • Student’s name
  • Course name and number
  • Instructor’s name
  • Date submitted
• Must use at least five peer-reviewed sources in addition to the course text.
• Must document all sources in APA style as outlined in the Ashford Writing Center.
• Must include a separate reference page that is formatted according to APA style as outlined in the Ashford Writing Center.

Carefully review the Grading Rubric (Links to an external site.)Links to an external site. for the criteria that will be used to evaluate your assignment.

Answer preview

When one has Alzheimer disease, there are cognitive changes that are likely to be witnesses which can reveal the presence of this disease. These manifestations are distinct from a healthy aging individual. As such, there will be witnessed a slowing down of mental processing and choice reaction. In other words, when the individual is compared to people of his/her age, they will exhibit slower and unhealthy cognition…

(3300 words)